Adtalem Global Education (NYSE:CVSA) Coverage Initiated by Analysts at Truist Financial

Truist Financial started coverage on shares of Adtalem Global Education (NYSE:CVSA) in a report released on Tuesday, MarketBeat.com reports. The firm issued a buy rating and a $130.00 price objective on the stock.

A number of other research analysts also recently issued reports on CVSA. Weiss Ratings initiated coverage on Adtalem Global Education in a report on Wednesday, February 25th. They set a “hold (c+)” rating for the company. Zacks Research upgraded Adtalem Global Education from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, February 24th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, March 2nd. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Adtalem Global Education currently has an average rating of “Buy” and an average price target of $150.00.

Adtalem Global Education Stock Up 3.2%

CVSA opened at $113.12 on Tuesday. The firm has a market capitalization of $3.90 billion, a P/E ratio of 16.61, a P/E/G ratio of 0.93 and a beta of 0.72. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 0.37. Adtalem Global Education has a 12 month low of $86.97 and a 12 month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last released its earnings results on Wednesday, January 28th. The company reported $2.43 earnings per share (EPS) for the quarter. The firm had revenue of $503.39 million during the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.

Insider Activity at Adtalem Global Education

In related news, Director Michael W. Malafronte acquired 8,890 shares of the business’s stock in a transaction dated Wednesday, March 11th. The stock was bought at an average price of $100.94 per share, with a total value of $897,356.60. Following the acquisition, the director owned 25,395 shares in the company, valued at $2,563,371.30. This represents a 53.86% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders purchased 37,236 shares of company stock valued at $3,752,866. Corporate insiders own 2.50% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.